Skip to content
Home/Companies/Biotech/SignaCor
SignaCor

SignaCor

Biotech·UK·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns SignaCor?

SignaCor is currently owned by Qubis through QUBIS Ltd (1984 vintage), since 2024.

Hand-verified · updated 2026-07-08

Qubis
Investor
Qubis
QUBIS Ltd · 1984 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive
Websitesignacor.co.uk

More from QUBIS Ltd

Other portfolio companies in the same fund.

InnovaScope
Active
MedTechUK· 2025
LoyalBe
LoyalBe
Active
FintechUK· 2025
ReNewVax
Active
BiotechUK· 2025
Retinize
Active
Deep TechUK· 2025
StimOxyGen
StimOxyGen
Active
BiotechUK· 2025
Birota
Active
Business ServicesUK· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track SignaCor

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy SignaCor?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on SignaCor.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue